跳至主要内容
临床试验/NL-OMON56644
NL-OMON56644撤回不适用

The residual heparin concentration in the autotransfusion system product in cardiothoracic surgery: A pilot study - The residual heparin concentration in the autotransfusion system product

Medisch Centrum Leeuwarden0 个研究点目标入组 45 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • The study population involves 45 patients undergoing on-pump CABG or/and AVR
  • procedure in the MCL, where ATS has been used. Male or female patients aged 18
  • years or older who were in a non-emergency situation are eligible.

排除标准

  • Exclusion criteria includes patients who were using anticoagulant medication
  • prior to surgery, patients with preoperative known coagulation problems and
  • liver problems (increased APTT/ALAT/ASAT values in Electronic Health Record
  • (EHR)). Also, patients in which hypothermia (<34 degrees Celsius) is used
  • during cardiopulmonary bypass (CPB) are excluded from this study.

研究者

发起方
Medisch Centrum Leeuwarden

相似试验